Extracorporeal Membrane Oxygenation (ECMO) is a salvage therapy used in patients with refractory cardiogenic shock. This rescue technique is associated to a high mortality rate and to many complications that can impact the quality of life of the survivors. The aim of this study is to evaluate the Health-related quality of life in adults after veino-arterial Extra-Corporeal Membrane Oxygenation. The quality of life will be evaluated thanks to several methods : the Short Form 36, the EQ 5D 5L and the return to work status. Then, the investigators will analyze by subgroup the quality of life according to the cardiogenic shock etiology and try to determine the risk factors of an altered quality of life. The investigators will also evaluate current comorbidities of the patient thanks to the Groll Index.
Study Type
OBSERVATIONAL
Enrollment
300
Quality of life will be evaluated thanks to several methods: Short Form 36, EQ 5D 5L and return to work status Questionnaires will be evaluated through postal and phone call at least 12 months after ECMO.
Les Hôpitaux Universitaires de Strasbourg
Strasbourg, France
RECRUITINGEvaluation of health-related quality of life after veino-arterial ECMO
Quality of life will be evaluated by Short Form 36 ( score 0 to 100)
Time frame: The quality of life will be evaluated from 1 to 12 years after the ECMO
Evaluation of health-related quality of life after veino-arterial ECMO
EQ 5D 5L ( description of mobility, personal autonomy, routine activities, pain and discomfort, anxiety and depression and an analog visual scale)
Time frame: The quality of life will be evaluated from 1 to 12 years after the ECMO
Analysis by subgroup according to the cardiogenic shock etiology
5 subgroups will be assessed according to the cardiogenic shock etiology: post cardiac surgery, post cardiac ischemia, pulmonary embolism or other right ventricle dysfunction, other etiology
Time frame: The quality of life will be evaluated from 1 to 12 years after the ECMO
Research of risk factors of an altered quality of life
5 subgroups will be assessed according to the cardiogenic shock etiology: post cardiac surgery, post cardiac ischemia, pulmonary embolism or other right ventricle dysfunction, other etiology
Time frame: The quality of life will be evaluated from 1 to 12 years after the ECMO
Evaluation of the current comorbidities thanks to Groll index
5 subgroups will be assessed according to the cardiogenic shock etiology: post cardiac surgery, post cardiac ischemia, pulmonary embolism or other right ventricle dysfunction, other etiology
Time frame: The quality of life will be evaluated from 1 to 12 years after the ECMO
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.